Cargando…

Comprehensive analysis of CTNNB1 in adrenocortical carcinomas: Identification of novel mutations and correlation to survival

The Wnt/β-Catenin signaling pathway is one of the most frequently altered pathways in adrenocortical carcinomas (ACCs). The aim of this study was to investigate the status of Wnt/β-Catenin signaling pathway by analyzing the expression level of β-Catenin and the mutational status of APC, AXIN2, CTNNB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maharjan, Rajani, Backman, Samuel, Åkerström, Tobias, Hellman, Per, Björklund, Peyman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988720/ https://www.ncbi.nlm.nih.gov/pubmed/29872083 http://dx.doi.org/10.1038/s41598-018-26799-2

Ejemplares similares

Activating mutations in CTNNB1 in aldosterone producing adenomas
por: Åkerström, Tobias, et al.
Publicado: (2016)

RNA Sequencing Provides Novel Insights into the Transcriptome of Aldosterone Producing Adenomas
por: Backman, Samuel, et al.
Publicado: (2019)

Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients
por: Björklund, Peyman, et al.
Publicado: (2008)

Global DNA Methylation Analysis Identifies Two Discrete clusters of Pheochromocytoma with Distinct Genomic and Genetic Alterations
por: Backman, Samuel, et al.
Publicado: (2017)

Integrative Genetic Characterization and Phenotype Correlations in Pheochromocytoma and Paraganglioma Tumours
por: Crona, Joakim, et al.
Publicado: (2014)

Nutlin‐3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation
por: Hui, Wen, et al.
Publicado: (2018)

Subcellular localization of fibroblast growth factor receptor type 2 and correlation with CTNNB1 genotype in adrenocortical carcinoma
por: Haase, Matthias, et al.
Publicado: (2020)

RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective
por: Crona, Joakim, et al.
Publicado: (2018)

Transcriptomic Characterization of Hepatocellular Carcinoma with CTNNB1 Mutation
por: Ding, Xiao, et al.
Publicado: (2014)

First-in-human evaluation of [(18)F]CETO: a novel tracer for adrenocortical tumours
por: Silins, Isabella, et al.
Publicado: (2022)

CTNNB1 Mutation in Aldosterone Producing Adenoma
por: Wang, Jian-Jhong, et al.
Publicado: (2017)

CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma
por: Apps, J. R., et al.
Publicado: (2020)

Recurrent CTNNB1 mutations in craniofacial osteomas
por: Baumhoer, Daniel, et al.
Publicado: (2021)

Identification and Functional Analysis of a Novel CTNNB1 Mutation in Pediatric Medulloblastoma
por: Alaña, Lide, et al.
Publicado: (2022)

Frequent somatic TERT promoter mutations and CTNNB1 mutations in hepatocellular carcinoma
por: Lee, Seung Eun, et al.
Publicado: (2016)

An LRP5 Receptor with Internal Deletion in Hyperparathyroid Tumors with Implications for Deregulated WNT/β-Catenin Signaling
por: Björklund, Peyman, et al.
Publicado: (2007)

25-Hydroxyvitamin D(3 )1α-hydroxylase expression in breast cancer and use of non-1α-hydroxylated vitamin D analogue
por: Segersten, Ulrika, et al.
Publicado: (2005)

Analysis of the Clinicopathologic Characteristics of Lung Adenocarcinoma With CTNNB1 Mutation
por: Zhou, Chao, et al.
Publicado: (2020)

Somatic mutations in CDH1 and CTNNB1 in primary carcinomas at 13 anatomic sites
por: Busch, Evan L., et al.
Publicado: (2017)

An oncogenic CTNNB1 mutation is predictive of post-operative recurrence-free survival in an EGFR-mutant lung adenocarcinoma
por: Kim, Yeseul, et al.
Publicado: (2023)

CTNNB1 in neurodevelopmental disorders
por: Zhuang, Wenting, et al.
Publicado: (2023)

Characteristics of cultured desmoid cells with different CTNNB1 mutation status
por: Hamada, Shunsuke, et al.
Publicado: (2015)

The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes
por: Wu, Vin-Cent, et al.
Publicado: (2017)

Exon 3 mutations of CTNNB1 drive tumorigenesis: a review
por: Gao, Chao, et al.
Publicado: (2017)

Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing
por: He, Juan, et al.
Publicado: (2021)

Familial Exudative Vitreoretinopathy and Systemic Abnormalities in Patients With CTNNB1 Mutations
por: Huang, Li, et al.
Publicado: (2023)

Comprehensive assessment and meta-analysis of the association between CTNNB1 polymorphisms and cancer risk
por: Li, Yanke, et al.
Publicado: (2017)

Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors
por: Goh, Gerald, et al.
Publicado: (2014)

Aberrant WNT/β-catenin signaling in parathyroid carcinoma
por: Svedlund, Jessica, et al.
Publicado: (2010)

An Integrative Analysis Reveals the Underlying Association Between CTNNB1 Mutation and Immunotherapy in Hepatocellular Carcinoma
por: Mo, Zhuomao, et al.
Publicado: (2020)

Prognostic significance of CTNNB1 mutation in hepatocellular carcinoma: a systematic review and meta-analysis
por: Lu, Genlin, et al.
Publicado: (2023)

The Role of CTNNB1 in Endometrial Cancer
por: Ledinek, Živa, et al.
Publicado: (2022)

The Internally Truncated LRP5 Receptor Presents a Therapeutic Target in Breast Cancer
por: Björklund, Peyman, et al.
Publicado: (2009)

Comprehensive Re-Sequencing of Adrenal Aldosterone Producing Lesions Reveal Three Somatic Mutations near the KCNJ5 Potassium Channel Selectivity Filter
por: Åkerström, Tobias, et al.
Publicado: (2012)

Detection of CTNNB1 Hotspot Mutations in Cell-Free DNA from the Urine of Hepatocellular Carcinoma Patients
por: Lin, Selena Y., et al.
Publicado: (2021)

PROP1 and CTNNB1 expression in adamantinomatous craniopharyngiomas with or without β-catenin mutations
por: Cani, Carolina M.G., et al.
Publicado: (2011)

Liver cancer with concomitant TP53 and CTNNB1 mutations: a case report
por: Friemel, Juliane, et al.
Publicado: (2016)

Trichoblastic carcinosarcoma with panfollicular differentiation (panfollicular carcinosarcoma) and CTNNB1 (beta‐catenin) mutation
por: Giang, Jenny, et al.
Publicado: (2020)

PIK3CA mutation in a case of CTNNB1-mutant sinonasal glomangiopericytoma
por: Hong, Christopher S., et al.
Publicado: (2022)

Correlation between Phenotype and Genotype in CTNNB1 Syndrome: A Systematic Review of the Literature
por: Miroševič, Špela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_njmba12rgoakfn9mqqjup18u7f